The Patent Finder

Ares Trading S.A.

61 patents currently held · Updated Nov 16, 2026
34 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 3 name spellings.

20
Ending by 2030
Dec 2026
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 25, 2027
    The maintenance fee for Anti-retroviral treatment using growth hormone (US 11,707,508) comes due Jan 25, 2027. Unpaid by Jul 26, 2027, it lapses early.
  • 1 fee due Mar 17, 2027
    The maintenance fee for Medical device connection station (US 10,417,384) comes due Mar 17, 2027. Unpaid by Sep 17, 2027, it lapses early.
  • 1 fee due May 3, 2027
    The maintenance fee for Apparatus, Method, and System for Image-Based Human Embryo Cell Classification (US 9,177,192) comes due May 3, 2027. Unpaid by Nov 3, 2027, it lapses early.
  • 3 fees due Jun 17 to 30, 2027 · next Jun 17
  • 1 fee due Jul 7, 2027
    The maintenance fee for Method of reducing serine for asparagine misincorporation (US 10,526,631) comes due Jul 7, 2027. Unpaid by Jan 7, 2028, it lapses early.
  • 1 fee due Nov 3, 2027
    The maintenance fee for Freeze-dried formulations of FGF-18 (US 9,326,944) comes due Nov 3, 2027. Unpaid by May 3, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 terms have ended since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 7,741,455Method for Purifying FSH
In force
 · High confidence
In forceHigh confidence
US 8,093,052Serum-free culture medium for the production of recombinant gonadotropins
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,309,069Human serum albumin-free stabilized interferon liquid formulations
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,998,842Injection Device With A Capacitive Proximity Sensor
In force
 · Low confidence
In forceLow confidence
US 7,866,203Method for the Quantitative Determination of Poloxamers
In force
 · High confidence
In forceHigh confidence
US 8,207,115Treatment of cartilage disorders with FGF-18
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,217,152Process for the Purification of IL-18 Binding Protein
In force
 · High confidence
In forceHigh confidence
US 7,846,427Stabilized interferon liquid formulations
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,043,254Medication delivery device
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,088,096Injection device with a capacitive proximity sensor
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 61 patents shown.
Pro members see all 61.
Pro members: see all 61 patents
Also on record, not counted in the 61: 34 patents in force now held by others · 52 lapsed for an unpaid fee · 34 ended at full term · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

12 pending · 14 abandoned · 46 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited